Preparation of clenbuterol imprinted monolithic polymer with hydrophilic outer layers by reversible addition–fragmentation chain transfer radical polymerization and its application in the clenbuterol determination from human serum by on-line solid-phase extraction/HPLC analysis
Authors:
- 19 March 2013
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 138 (10) , 3066-3074
Abstract
A novel imprinted monolithic material with the ability of protein exclusion was developed for the selective extraction of clenbuterol (CLE) from biological samples by direct injection in the HPLC analysis. The material has an imprinted inner structure and hydrophilic outer layer. The reversible addition–fragmentation chain transfer (RAFT) polymerization was employed in the material preparation by a two-step procedure. In the first step, clenbuterol imprinted monolithic polymer was synthesized by combining the molecular imprinting and the RAFT polymerization techniques. The resulting monolithic polymer has a RAFT chain transfer agent (trithioester groups) in its structure, which was used to graft poly(glycerol mono-methacrylate) [pGMMA] in the second step by post-RAFT polymerization. The hydrophilic pGMMA layers grafted on the surface of the imprinted monolith created barriers for protein diffusion. More than 90% of bovine serum albumin can be excluded from the pGMMA coated monolithic column. Meanwhile the clenbuterol was retained selectively with a large retention factor. The result indicated that the column, denoted as RA-MIM, has both the merits of a molecularly imprinted polymer and restricted access material. By using RA-MIM as the solid-phase extraction pre-column, an on-line column-switching HPLC method for the determination of clenbuterol in human serum has been established and validated. The recoveries of clenbuterol from the serum were 87.3–96.9% in the spiked level 2–1000 ng mL−1. Both good linearity (R = 0.999) and acceptable reproducibility (RSD < 7.0%) were obtained. The limit of detection and the limit of quantitation were 0.7 ng mL−1 and 2.0 ng mL−1 respectively, which is sensitive in terms of UV detection. The results have demonstrated that the RAFT polymerization can be used to synthesize bi-functional monolithic columns by using its living reaction property. The resulting RA-MIM in this research can be used for efficient clenbuterol determination by HPLC from biological samples.Keywords
This publication has 30 references indexed in Scilit:
- Preparation of Monolithic Imprinted Stationary Phase for Clenbuterol by In Situ Polymerization and Application in Biological Samples PretreatmentChromatographia, 2011
- Surface hydrophilic modification with a sugar moiety for a uniform-sized polymer molecularly imprinted for phenobarbital in serumActa Biomaterialia, 2011
- Recent developments and applications of molecularly imprinted monolithic column for HPLC and CECJournal of Separation Science, 2011
- Molecularly imprinted polymers for sample preparation: A reviewAnalytica Chimica Acta, 2010
- Evaluation of the clenbuterol imprinted monolithic column prepared by reversible addition-fragmentation chain transfer polymerizationChinese Chemical Letters, 2009
- Development of restricted-access media supports and their application to the direct analysis of biological fluid samples via high-performance liquid chromatographyAnalytical and Bioanalytical Chemistry, 2006
- Novel surface modified molecularly imprinted polymer focused on the removal of interference in environmental water samples for chromatographic determinationJournal of Chromatography A, 2005
- Determination of clenbuterol, ractopamine and zilpaterol in liver and urine by liquid chromatography tandem mass spectrometryAnalytica Chimica Acta, 2005
- The analysis of beta-agonists in bovine muscle using molecular imprinted polymers with ion trap LCMS screeningAnalytica Chimica Acta, 2005
- Three-way models and detection capability of a gas chromatography–mass spectrometry method for the determination of clenbuterol in several biological matrices: the 2002/657/EC European DecisionAnalytica Chimica Acta, 2004